Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05004415 · ClinicalTrials.gov registry record · Phase 1

Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)

A Phase 1 study of Healthy Volunteer Study, sponsored by Atea Pharmaceuticals.

Completed
Registry status
Phase 1
Development phase
6
Enrollment target
1
Study location

NCT05004415 is a Phase 1 study of Healthy Volunteer Study that has completed, run by Atea Pharmaceuticals. The registered enrollment target is 6 participants, below the 36-participant average among 9 other Healthy Volunteer Study trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05004415, a Phase 1 study of Healthy Volunteer Study, has completed, sponsored by Atea Pharmaceuticals.

COMPLETED
Registry status
Phase 1
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Mass balance study of AT-527 in Healthy Male Subjects.

Conditions Studied

Interventions

  • DRUG AT-527 (R07496998)

Study Locations (1)

Nebraska

  • Atea Study Site - Lincoln

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-07-28
Est. Completion 2021-08-12
Phase Phase 1

Sponsor

Atea Pharmaceuticals

12 total trials

What the Registry Record Tells You About NCT05004415

The ClinicalTrials.gov registry entry for NCT05004415 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36-participant average among 9 other Healthy Volunteer Study trials with a reported enrollment target (83% lower). The listed sponsor is Atea Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Volunteer Study appearing as the primary indexed condition, and to 1 intervention - of which AT-527 (R07496998) is the first listed.

NCT05004415 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT05004415 about?

NCT05004415 is a clinical study titled "Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)". Mass balance study of AT-527 in Healthy Male Subjects.

What is the current status of trial NCT05004415?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2021-07-28. Estimated completion is 2021-08-12.

What conditions does trial NCT05004415 study?

This clinical trial studies the following conditions: Healthy Volunteer Study.

What interventions are being tested in trial NCT05004415?

The interventions under investigation include: AT-527 (R07496998) (DRUG).

Who is sponsoring clinical trial NCT05004415?

This trial is sponsored by Atea Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05004415 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteer Study

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.